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ABSTRACT
Molecular Modulation of α-Subunit VISIT-DG Sequence Residue Asp-350 in the Catalytic sites
of Escherichia coli ATP Synthase
by
Sneha Reddy Jonnalagadda
ATP Synthase is the fundamental means of cellular energy production in animals, plants, and
almost all microorganisms. In order to understand the mechanism of ATP catalysis, critical
amino acid residues involved in Pi binding have to be identified. The αVISIT-DG sequence at
the interface of α/β subunits that contains residues from 345-351 is highly conserved and αAsp350 has been chosen because of its negative charge side chain and its close proximity (~2.8 Å) to
the known phosphate binding residue αArg-376. The mutant’s αD350R, αD350Q, αD350A,
αR376A/D, and αG351R/A/D were generated by site directed mutagenesis and several
biochemical assays were performed on them to understand the role played by the amino acid
residues in Pi binding. Biochemical results suggest that αD350 may be involved in catalysis of
ATP synthase and play an important role in Pi binding, whereas αG351 may be involved only in
the structural integrity.
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CHAPTER 1

INTRODUCTION

ATP synthase, also known as F1Fo –ATPase, is the fundamental means of energy
production that catalyzes the synthesis of ATP during oxidative phosphorylation or
photophosphorylation. The enzyme is capable of hydrolyzing and synthesizing ATP in a
reversible reaction. The enzyme was discovered in 1929 by Karl Lohmann, and in 1935 Vladimir
Engelhart noted that muscle contractions require ATP. Fritz Lipmann demonstrated that ATP is
the main bearer of chemical energy in the cell in 1941, and Alexander Todd synthesised ATP
chemically in 1948. Slater proposed a scheme showing the chemical intermediates to explain the
mechanism of oxidative phosphorylation [1]. Coupled oxidative phosphorylation was shown to
be activated by a soluble factor in bacteria particulate [2]. Soluble adenosine triphosphatase was
then shown to participate in oxidative phosphorylation [3]. The chemiosmotic hypothesis
postulated the primary role of membranes that separate 2 compartments and therefore maintains
a gradient of proton activity, generated by respiration chain enzymes, that was used by ATP
synthase [4]. On the basis of the kinetics of enzyme-catalysed 18O exchange between H2O and
Pi/ATP, a binding change mechanism was proposed. The binding change mechanism involves
the active site of a β subunit cycling between three states. In the "open" state, ADP and
phosphate enters the active site where the protein then closes up around the molecules and binds
them loosely. The enzyme then undergoes another change in shape and forces these molecules
together, with the active site in the resulting tight state binding the newly-produced ATP
molecule with very high affinity. The active site then cycles back to the open state, releasing
9

ATP and binding more ADP and phosphate, ready for the next cycle of ATP production. The F1
catalytic domain of ATP synthase was crystallized, which essentially supported the hypothesis
that Boyer’s binding change mechanism was correct.

In view of the fact that ATP synthase uses ATP to drive proton gradient for transport
purposes, it is highly conserved in all organisms. In Escherichia coli, ATP synthase has 2 major
components (F1 and Fo) and 8 different subunits (α3, β3, γ, δ, ε, a, b, c10-15). The water soluble F1
sector is made up of 3α subunits, 3β subunits and one each of γ, δ, and ε subunits. The membrane
embedded Fo sector consists of 1a, 2b and 10-15c subunits [Fig 1]. The overall molecular mass
of the complex is ~530KDa.
ATP synthase has 3 catalytic sites located on the α/β interface. Proton pumping occurs
through membrane embedded F0 sector [5, 6]. The F1 subunit is part of the “rotor” that is composed

of γ,ε, and a ring of c subunits. The γ-subunit is comprised of three α-helices. 2 of these helices
form a coiled coil that go right up into the central space of the α3ß3 hexagon. The “stator” is
composed of 2 b and δ subunits. The function of the stator is to prevent co-rotation of catalytic
sites and the ‘a’ subunit with the rotor [7, 8]. Proton gradient-driven clockwise rotation of γ (as
viewed from the membrane) leads to ATP synthesis and anticlockwise rotation of γ results in
ATP hydrolysis. ATP synthase works like a motor and in fact it is the smallest known biological
nanomotor. Detailed reviews of ATP syntheses structure and function may be found in
references [9-16].
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Figure 1: The Rotary Mechanism of ATP Synthase. (Reproduced from [42] with permission;
copyright Elsevier).The enzyme consists of 2 sectors catalytic F1 and membrane bound Fo. F1
consists of α3, β3, γ, δ, and ε. Fo consists of ab2c10. In mitochondria and chloroplasts additional
subunits are present. The rotor stalk indicates the helical coiled-coil extension of the γ subunit
into the central cavity of the α3/ β3 hexagon. The rotor is composed of γ, δ, and a ring of c
subunits. The “stator” is composed of b2δ. The proton pathway lies between ‘a’ and ‘c’ subunits.
[39]
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Determining the Reaction Mechanism of ATP Synthase
In order to understand the reaction mechanism of ATP synthesis and hydrolysis and their
relationship to rotation in this biological nanomotor, our lab has focused mainly on
•

Understanding the role of conserved residues in and around catalytic site Pi-binding
sub-domain [22].

•

Modulating the catalytic site for improved catalytic and motor function of the
enzyme.

•

Understanding the relationship between Pi binding and subunit rotation [20-22].

•

How ATP synthase binds ADP and Pi within its catalytic sites in the face of relatively
high ATP/ADP concentration ratio.

Importance of VISIT-DG
The α-subunit Valine, Isoleucine, Serine, Isoleucine, Threonine, Aspartate, Glycine
(VISIT-DG) [Fig 2] residues are highly conserved throughout all living organisms. Earlier αArg376, βArg-182, βLys-155, and βArg-246 were shown to be involved in Pi binding [20, 22].
Recently αSer-347 of VISIT-DG sequence was also indentified as a fifth Pi binding residue [22,
Fig 3]. Generally, the other VISIT-DG sequence residues are of special interest and in particular,
αAsp-350 is of special interest due to its negative charge. This residue is also in close proximity
(~2Å) to αArg-376, a known Pi binding residue. Here, we would like to investigate the role of
αAsp-350 in direct/ indirect Pi binding and or in the maintenance of the Pi binding subdomain.
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Figure 2: Amino Acid Sequence Alignment of Evolutionarily Conserved α-subunit VISIT-DG
Sequence. (Adapted from [22] with permission from ASBMB, 2009) α- subunit sequence from
different species is aligned. The highly conserved VISIT-DG sequence is highlighted in gray.
The starting residue arginine shown here for E. coli is αR300. [22]

Figure 3: X-Ray Crystal Structure of Catalytic Sites in the α-subunit of Mitochondrial ATP
Synthase. (Adapted from [22] with permission from ASBMB, 2009) The triangle showing the
residues βR182, βK155, αR376, βR246, αS347 together form a catalytic triad. αD350 is of
special interest due to its close proximity (~2Ao) to a known Pi binding residue αR376.Residues
in the boxes define the VISIT-DG. [22]
13

Inhibition of ATP Synthase
7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) is a potent inhibitor of ATP
synthase. It provides a measure of the Pi binding. NBD-Cl reacts with the phenolic oxygen of
Tyr-311 of the βE subunit that contains no bound nucleotide. The 2 other catalytic subunits βTP
and βDP contain bound adenylyl-imidodiphosphate (AMP-PNP) and ADP respectively. The
binding site of the NBD moiety doesn’t overlap with the regions of βE that form the nucleotide
binding pocket in subunits βTP and βDP, nor does it occlude the nucleotide-binding site.
Catalysis appears to be inhibited because neither βTP nor βDP can accommodate a Tyr-311
residue bearing a NBD group. NBD-Cl inhibits the enzyme by preventing the modified subunit
from adopting a confirmation that is essential for catalysis to proceed. NBD-Cl forms a covalent
adducts with βTyr-297 in E.coli at a stoichiometry of 1mol/mol and inhibits F1 ATPase activity
[17]. NBD-Cl reacts only in the empty (βE) catalytic site, and it doesn’t act as a nucleotide
analog based on the location of the derivatized Tyr residue in the X-ray structure.
This was supported by the 2 lines of evidence. Pseudo-first order rate constant for
inhibition (KObs) was linearly dependent upon NBD-Cl concentration, implying that no initial
binding event was required. Secondly, MgADP protected purified F1 and F1Fo in membrane from
reaction with NBD-Cl, but only at extremely high concentration that would effectively keep the
third site (βE) occupied in time average and thus impede access by NBD-Cl by closing the site
[17]. Eventually Perez et al. [18] reported that Pi protection against NBD-Cl inhibition of
ATPase activity of ATP synthase in mitochondrial membrane preparations, potentially a tool to
assay Pi binding in βE catalytic site. This was applicable to both membrane bound enzyme and
with purified F1 from E. coli [9]. Several inhibitory studies were performed using transition state
analogs. The transition state analog MgADP-AlF4- trapped in catalytic sites has been visualized
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by x-ray crystallography [19], and it is clear that the fluoroaluminate group occupies the position
of phosphate in the transition state complex can be compared by assay of inhibition of ATPase
activity by MgADP-fluoroaluminate (MgADP-fluoroscandium) in mutant and wild-type
enzymes [20, 21].

Hypotheses
•

The highly conserved α-subunit VISIT-DG sequence residue Asp-350 is directly or
indirectly involved in phosphate binding through αArg-376.

•

αAsp-350 is important for function through its role in maintaining the structural integrity

of the Pi binding subdomain and not involved in Pi binding per se.
•

The carboxyl side chain of αAsp-350 may be involved in establishing transition state.

•

The compensatory effect of αD350 can be determined through αD350R/αR376A and
repulsive effect through αD350/αR376D [13]. This can help in exploring the role of
αD350 in Pi binding and/or structural integrity.
The aspartate and glycine residues of VISIT –DG sequence have been replaced by

various other amino acids such as arginine, glutamine, alanine, etc through site directed
mutagenesis. Left and right oligonucleotides were designed with the desired mutations. The
single stranded template DNA was amplified in PCR using DNA polymerase and primers. These
plasmids, thus obtained, were then transformed into the DK8 strain that lacks ATP synthase
gene. The plasmids isolated from DK8 were then sent to sequencing to confirm the presence of
desired mutations. Once the desired mutants are obtained, several inhibitory studies were carried
on the membranes of different mutants. These inhibitory studies enable us to understand the role
played by different residues in phosphate binding.
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CHAPTER 2

MATERIALS AND METHODS

Chemicals
Adenosine 5 -triphosphatase disodium salt, ampicillin, glucose, succinic acid, uracil,
TES, TRIZMA (Tris[Hydroxyethyl] ethane), 4-aminobenzamidine dihydrchloride (PAB), SDS
(Sodium dodecyl sulfate), Isopropyl β-D-1-thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3indolyl- beta-D-galactopyranoside (X-Gal), βmercaptoethanol, agarose, adenosine 5’diphosphate (ADP), 4-chloro-7-nitrobenzofurazan (NBD-Cl) , N,N'-dicyclohexylcarbodiimide
(DCCD), dithiothreitol (DTT), sodium fluoride (NaF), aluminum chloride(AlCl3), and scandium
chloride(SnCl3) were purchased from Sigma–Aldrich Chemical Company.

Buffers and Reagents
50mM Tris-H2SO4 (pH-8), ATPase assay buffer, T&S reagent (Taussky and Shorr
reagent), 10%SDS, TE(trace elements), 1M MgSO4, AET (Arginine Ent Thiamine),
ILV(isoleucin-valine), STEM, TES 50, and TES5 +PAB, 10x reaction buffer, dNTP mix, quick
solution reagent, cell resuspension solution, column wash solution, and neutralization solution
were prepared as described in Appendix B.

Culture Media
LB medium, minimal media, limiting glucose, succinate media, NZY broth, XL ultra
competent cells, and culture media (liquid and plates) were prepared as described in Appendix C.
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All other standard chemicals used in this study were ultra pure analytical grade purchased either
from Sigma-Aldrich Chemical Company or Fisher Scientific Company.

Equipment
Table top centrifuge (Thermo Scientific), Polymerase chain reactor, Gel doc, Stasar III
Colorimeter (Gilford, Oberlin, OH) Evolution-300 UV-Visible Spectrophotometer (Thermo
Scientific, Pittsford, NY), French press, cell disrupter (Thermo Scientific, Asheville, NC), C76
Water Bath shaker (New Brunswick Scientific Co. inc, Edison, NJ ), Sorvall WX ultra 80, Ultra
Centrifuge (Thermo Scientific, Asheville, NC), Sorvall RC-5Bsuper speed Centrifuge (Thermo
Scientific, Asheville, NC), Series 25, and incubator shaker (New Brunswick Scientific Co. inc,
Edison, NJ ) were used during experiments.

Designing the Primers
The mutagenic primers must contain the desired mutations and anneal to the same
sequence on the opposite strand of the plasmid. The primers were designed with a minimum GC
content of 40% and approximately of 25 to 45 bases in length with a Tm>78°C. The desired
mutation was in the middle of the primer with ~10-15 bases of correct sequence on both sides.

Site-Directed Mutagenesis
Mutagenesis was performed using Quick-change site directed mutagenesis kit [26]. In
site directed mutagenesis a super coiled double stranded DNA vector (M13mp18) with an insert
of interest (α-subunit of E. coli ATP synthase) has been used. The left and right oligonucleotides
were synthesized with the desired mutation and were used during reaction. The left and right
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primers, each complementary to the vector, are extended in a polymerase chain reaction by DNA
polymerase. Thus, the mutant plasmids with the nicks were generated. These nicks were cleaved
by DpnI endonucleases and the nicked mutated plasmid DNA was transformed into XL1supercompetent cells. The plasmids from these mutants were isolated and transformed into DK8
strains that lack ATP synthase gene. The reaction procedure is described as below.
The control reaction was prepared using 10x Reaction buffer, 10ng of pBW4.5kb control
plasmid (5ng/µl), 125ng of oligo control primer1 [34mer (100ng/µl)], 125ng of oligo control
primer2 [34mer (100ng/µl)], 1µl of dNTP mix, and 3µl of quick solution reagent. The final
volume was made to 50µl using water. The sample reaction was prepared using 5µl of 10x
reaction buffer, 10-100ng of dsDNA template, 125ng of oligo primer1, 125ng of oligo primer2,
1µl of dNTP mix, and 3µl of quick solution reagent. Final volume was made to 50µl using water.
1µl (2.5U/µl) of quick change lightning enzyme (DNA polymerase) was added to each of the
control and sample reactions. The cycling parameters for PCR are shown in Table 1.
Table1: Cycling Parameters for the Polymerase Chain Reaction
Segment Cycle
1

1

2

18

3

1

Temperature

Time

95°C

2min

95°C, 60°C, 68°C 20sec,10sec,30sec/kb
68°C

5min

Once the PCR was done, DpnI restriction enzyme was added to each of the vials [26].
The reactions were incubated for 1 hour to digest the parental (i.e: the nonmutated) super coiled
dsDNA. In order to transform, XL10 ultra competent cells were used. 45µl of ultra competent
cells were aliquoted and mixed with 2µl of βmercaptoethanol to improve transformation
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efficiencies. The mixture was incubated on ice for 10 minutes. 2µl of DpnI treated DNA from
control and sample reactions were transferred into separate aliquots of ultra competent cells and
incubated on ice for 30 minutes. The tubes were given heat pulse for about 30 seconds and
immediately placed on ice for 2 minutes. 0.5ml of NZY broth was added to each tube and
allowed it to incubate at 37°C for 1 hour with shaking at 225-250 rpm. Cells were spread on LBAMP agar plates containing 80µg/µl X-Gal and 20mM IPTG, and the plates were incubated at
37°C for more than 16 hrs. Once the positive colonies were observed, they are picked and grown
in LB-AMP broth for 6-8 hrs. The plasmids were isolated using Promega mini prep kit.

Plasmid Isolation
10ml (low-copy-number plasmid) of bacterial culture was harvested by centrifugation for
5 minutes at 10,000 x g in a tabletop centrifuge. The supernatant was discarded and the tubes
were inverted to remove the excess media. 250µl of cell resuspension solution was added, and
the cell pellet was thoroughly resuspended by pipetting. 250µl of cell lysis solution was added,
and mixed by inverting the tube 4 times. The tubes were incubated for 1-5minutes until the cell
suspension is cleared. 10µl of alkaline protease solution was added and mixed by inverting the
tubes 4 times and were incubated for 5 minutes at room temperature. Alkaline protease
inactivates endonucleases and other proteins released during the lysis of the bacterial cells that
can adversely affect the quality of the isolated DNA. The incubation should not exceed for more
than 5 minutes with alkaline protease solution, as nicking of the plasmid DNA may occur. 350µl
of neutralization solution was added and mixed immediately by inverting the tubes 4 times. The
lysate was centrifuged at maximum speed (around 14,000 × g) in a micro centrifuge for 10
minutes at room temperature. The cleared lysate was transferred to the spin column by decanting.
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The supernatant was centrifuged at maximum speed in a micro centrifuge for 1 minute at room
temperature and the spin column was removed from the tube, and flow through was discarded
from the collection tube. To the spin column, 750µl of column wash solution was added and
centrifuged at maximum speed for 1 minute. The supernatant was discarded and again washed
with column wash solution by centrifuging at maximum speed for 1minute. The spin column was
transferred to a new, sterile 1.5ml micro centrifuge tube.100µl of nuclease-free water was added
to the spin column and centrifuged to elute the plasmid DNA. Plasmid DNA was stored at –20°C
or below in water.
Once the plasmids were isolated, restriction digestion was performed with specific
enzymes for each mutation. The bands were observed on 1% agarose gel electrophoresis using
standard protocol. Once the bands of required length are obtained, the plasmids were sent to
sequencing. Sequencing results confirmed the presence of mutation and the plasmids with the
desired mutation were again transformed into DK8 strain using electroporation method [23, 24].
The mutants were thus obtained and can be used for further experiments.

Growth Yield on Succinate and in Limiting Glucose [28]
The colonies of each mutant strain were streaked on to succinate plates and were
observed for 3 days. The mutant strains were inoculated into limiting glucose and allowed to
grow at 37°C, 250 rpm in water bath. The O.D was observed at 595nm for every hour till late log
phase. This determines the amount of the membrane to be used and time of incubation.
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Preparation of E. coli Membrane Bound ATP Synthase [27]
Starter Culture
Minimal media was prepared in one large batch and distributed into 250ml flasks with
50ml each for better aeration. Necessary additions were made and the flasks were inoculated
with 10-15ml LB-AMP broth that has been previously grown overnight (16-20hrs) at 37°C, 250
rpm and allowed to grow for 6-8 hrs in 37°C water/air shaker at 250 rpm. These were used as
inoculums for 1litre flasks.

Bacterial Growth
50ml of overnight starter cultures were inoculated into 1litre minimal media and grown at
37°C, 250 rpm. Growth yield was measured at O.D595 every hour till late log phase. Once the late
log phase was obtained, the cells were harvested.

Harvesting the Cells
The cells were harvested by spinning the culture at 2°C in a Sorvall RC-5B refrigerated
Super speed centrifuge at 9500 rpm for 15 min. The harvested sample was resuspended in STEM
and centrifuged at 9500 rpm for 25 min. The supernatant was discarded and the pellet is
resuspended in 2 ml STEM/g wet cells and was stored at -80°C overnight.

Membrane Bound ATP Synthase Isolation
Cells from overnight were thawed and mixed with DNAse to digest nucleic acids. The
cells were then disrupted by 2 passages through chilled French press cell fractionator at 2000 psi.
Cell debris was pelleted by centrifugation at 18K rpm for 20 min using Sorvall WX ultra-80,
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Ultra Centrifuge. Subsequently, the membranes were pelleted by spinning the supernatant at 60K
rpm for 120 min. The membrane was then resuspended in TES 50 and centrifuged at 60K rpm
for 120 min. The pellet was then washed with TES 5 + PAB by spinning twice at 60K rpm for 90
min. Finally the purified membrane was resuspended in 50mM Tris Sulfate (pH 8), 2.5mM
MgSO4 and stored at -80°C.

Membrane Concentration and ATPase Assay
Membrane concentrations were found by plotting the absorbance at 595nm using
Bradford reagent against standard BSA curve. Amount of membrane and time of incubation
depends on growth assays and vary with each preparation. ATPase activity was measured by
adding 1 ml of assay buffer containing 10mM NaATP, 4mM MgCl2, 50mM TrisSO4(pH 8) to
the purified F1 or membranes at 37°C and stopped by addition of SDS to 3.3% final
concentration. Pi release was assayed by adding 1 ml of T&S reagent containing 10mM
(NH4)6Mo7O24·4H2O , 250mM Fe(NH4)2(SO4)2·6H2O, and 1.176 N H2SO4 [29]. The color
that developed was measured using a Stasar III Colorimeter at 700 nm. A graph is plotted using
Sigma plot software with activity on X-axis and OD700 on Y-axis. There is a straight line
relationship between the calorimetric reading and the concentration of phosphate. The reaction
is:

ATP + ATP Synthase
Pi + T&S

ADP + Pi
Blue color measured at O.D700

Specific Activity= (Sample O.D- Blank O.D) / [Amount (mg)*Time (min)]
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Inhibition of ATPase Activity by NBD-Cl
The three catalytic sites located on the F1 sector of ATPase are βTP, βDP, βE. Pi are
supposed to bind in the βE site for ATP synthesis. Fortuitously, NBD-Cl reacts specifically in the
βE site thus preventing the ATP synthesis [17]. NBD-Cl reacts with NBD-Cl was prepared as a
stock solution in dimethyl sulfoxide and protected from light. The membranes were reacted with
different concentrations of NBD-Cl for 60min in dark at room temperature in 50mM Tris-SO4
(pH 8), 2.5mM MgSO4. Then, 1ml of ATPase assay buffer was added into the tubes and allowed
to incubate at varied times for different mutants. The reaction was stopped by 10%SDS and
ATPase activity was determined after adding T&S at O.D700
•

50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + ATPcktl + 10% SDS +T&S (2-5 min)

•

50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 10% SDS +T&S (2-5 min)

Extra Pulse of NBD-Cl
It was mainly performed to see whether the maximal reaction with NBD-Cl occurred or
not. The membrane was incubated in dark with 150µM NBD-Cl for 60min at room temperature
in 50mM Tris-SO4, 2.5mM MgSO4, and then, an extra pulse of 200µM NBD-Cl was added and
incubated for another 60min. Then, 1ml of ATPase assay buffer was added into the tubes and
allowed to incubate at varied timings for different mutants. The reaction was stopped by
10%SDS and ATPase activity was determined after adding T&S at O.D700
•

50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 200µM NBD-Cl (inc 1h) + ATPcktl + 10%
SDS +T&S (2-5 min).

•

50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 200µM NBD-Cl (inc 1h) + 10% SDS +
ATPcktl + T&S (2-5 min).

23

DTT Reversibility
NBD-Cl inhibition was reversed by incubating the membranes with DTT for 60min at
room temperature. NBD-Cl incubations are performed in the dark where as DTT should be
maintained cool. The control samples without NBD-Cl and/or DTT were incubated for the same times.
Then, 1ml of ATPase assay buffer was added into the tubes and allowed to incubate at varied
timings for different mutants. The reaction was stopped by 10%SDS and ATPase activity was
determined after adding T&S at O.D700.
•

50mM T8 + Mbr + ATPcktl + 10% SDS + T&S (2-5 min)

•

50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + ATPcktl + 10% SDS + T&S (2-5 min)

•

50mM T8 + Mbr + 150 µM NBD-Cl (inc 1h) + 4mM DTT (inc 1h) + ATPcktl + 10% SDS
+ T&S (2-5 min)

•

50mM T8 + Mbr + 4mM DTT (inc 1h) + ATPcktl + 10% SDS + T&S (2-5 min)

Mg Pi Protection Against NBD-Cl
The membranes were preincubated for 60min with Pi and an equimolar Mg+2 at room
temperature in 50mM Tris-SO4, 2.5mM MgSO4. The concentration of Pi ranged from 25mM to
100mM. 150µM NBD-Cl was added to the above tubes and incubated at room temperature in the
dark for 60min.The control contained the protecting agent without NBD-Cl. Then, 1ml of
ATPase assay buffer was added into the tubes and allowed to incubate at varied timings for
different mutants. The reaction was stopped by 10%SDS and ATPase activity was determined
after adding T&S at O.D700
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MgADP Protection Against NBD-Cl
The membrane was incubated with MgADP with varied concentrations ranging from 012mM before adding NBD-Cl. The concentrations of Mg and ADP should be in 1:1 ratio. Then,
150µM NBD-Cl was added to it and incubated at room temp in the dark for 60min. The control
contained MgADP without NBD-Cl and MgADP alone has no inhibitory effect. Then, 1ml of
ATPase assay buffer was added into the tubes and allowed to incubate at varied timings for
different mutants. The reaction was stopped by 10%SDS and ATPase activity was determined
after adding T&S at O.D700

Inhibition of ATPase Activity by Transition State Analogs
The membranes were incubated for 60 min at room temperature in 50mM TrisSO4,
2.5mM MgSO4, 1mM NaADP, and 10mM NaF at a protein concentration of 0.2–0.5 mg/ml in
presence of AlCl3 or ScCl3 added at varied concentrations. 50µl aliquots were then added to 1 ml
of ATPase assay buffer, and activity was measured at O.D700. It was confirmed in control
experiments that no inhibition was seen if MgSO4, NaADP, or NaF was omitted.
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CHAPTER 3

RESULTS
Designing the Mutations and the Enzymes Used to Identify the Mutation
The site directed mutagenesis was performed and the mutants were obtained. The αAsp350 was mutated to Arginine(R), Glutamine (Q), and Alanine (A). The αArg-376 was mutated to
Alanine (A) and Glutamate (D) and the αGly-351 to Arginine (R). The double mutants were also
generated to see the repulsive and compensatory effects. The enzymes shown in the Table 2 are
used in the restriction digestion of the mutated site. DNA sequencing results confirmed the
presence or absence of the mutations.
Table 2: Table Representing the Name, Mutated Site, and Enzymes
Name and Mutated site

Mutation

Enzyme

pSR1 (αD350R)

GAT(D)→CGT(R)

PmlI

pSR2 (αD350Q)

GAT(D)→CAG(Q)

DdeI

pSR3 (αD350A)

GAT(D)→GCG(A)

SacII

pSR4 (αR376A)

CGT(R)→GCC(A)

EagI

pSR5 (αG351R)

GGT(G)→CGT(R)

PvuI

pSR6 (αR376D)

CGT(R)→GAC(D)

AatII

pSR7 (αD350R/ αR376A)

GAT→CGT/CGT→GCC

PmlI-EagI

pSR8 (αD350R/ αR376D)

GAT→CGT/CGT→GAC PmlI-AatII

pSR9 (αG351R/ αR376A)

GGT→CGT/CGT→GCC

PvuI-EagI

pSR10 (αG351R/ αR376D) GGT→CGT/CGT→GAC PvuI-AatII

26

Growth Yield on Succinate and in Limiting Glucose
A series of mutants were generated. The residue aspartate was chosen for mutagenesis
because of its strong conservation in the α-subunit VISIT-DG sequence and its close proximity
to the Pi binding pocket. αR376, which is a known Pi binding residue, was also modulated.
αD350R /αR376A/D were designed to test the compensatory effect and αD350/αR376D was
designed to test the repulsive effect. Table 3 shows that the introduction of arginine and alanine
in αD350 and alanine in αR376 resulted in loss of oxidative phosphorylation. Growth yields
were very close to null control where as all the double mutants showed partial loss of oxidative
phosphorylation. ATPase activities of αD350R, αD350A, αR376A, αG351R are very low when
compared to the wild type. However αD350R/αR376A did restore ATPase activity significantly,
but the rest of the double mutants are still showing low ATPase activities.
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Table 3: Effects of αD350 and αR376 Mutations on Cell Growth and ATPase Activity
Mutation a

Growth on Succinate b

Growth Yield in

ATPase Activity c

Limiting glucose (%)

(µmol/min/mg)

Wild type

++++

100

11.28

Null

-

52.69

0

(αD350R)

+/-

55

.03

(αD350Q)

++++

65

2.19

(αD350A)

+/-

49

.07

(αR376A)

+/-

56

.06

(αG351R)

+/-

58

.03

(αR376D)

+++

56

.19

(αD350R/ αR376A)

++

73

.46

(αD350R/ αR376D)

+++

68

.04

(αG351R/ αR376A)

+++

61.98

.04

(αG351R/ αR376D)

+++

68

.03

a

Wild type, pBWU13.4/DK8; Null, PUC118/DK8;
Growth on succinate plates after 3 days estimated by eye. ++++, heavy growth; +, partial
growth; +/-, very low growth; -, no growth
c
ATPase activity was measured at 37°C and expressed as µmol of ATP hydrolyzed/ min/ mg of
membrane protein.

b
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Inhibition of ATPase Activity of ATP Synthase by NBD-Cl
NBD-Cl reacts with the phenolic oxygen of Tyr-311 of the βE subunit that contains no
bound nucleotide. The 2 other catalytic subunits βTP and βDP contain bound adenylylimidodiphosphate (AMP-PNP) and ADP respectively. The binding site of the NBD moiety
doesn’t overlap with the regions of βE that form the nucleotide binding pocket in subunits βTP
and βDP, nor does it occlude the nucleotide-binding site. Catalysis appears to be inhibited
because neither βTP nor βDP can accommodate a Tyr-311 residue bearing a NBD group [17].
The NBD-Cl inhibition of each mutant with respect to wild type is shown in Figure 4.
Wild type ATP synthase enzyme is shows 100% inhibition, whereas all the newly generated
mutants aren’t. The αD350Q was almost completely inhibited just like wild type whereas
αD350R, αR376D, αD350R/ αR376A, mutants are showing ~80-90% inhibition with 10-20%
residual activity. αD350A, αR376A, αG351R/αR376A, αG351R/αR376D mutants are showing
60% inhibition whereas αD350R/αR376D, αG351R are showing 20% inhibition. All the mutants
show residual activity. So, in order to see whether NBD-Cl is completely inhibiting the ATP
synthase enzyme or not, an extra pulse of NBD-Cl was added.
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Figure 4: Inhibition of ATPase Activity of Mutants by NBD-Cl. The membranes were
preincubated with NBD-Cl for 60 min at RT. The assay was performed as discussed in
“Materials and Methods”. The solid circles determine wild type and rectangles represent
mutants.(Continued on the next page)

30

Figure 4: Inhibition of ATPase Activity of Mutants by NBD-Cl. The membranes were
preincubated with NBD-Cl for 60 min at RT. The assay was performed as discussed in
“Materials and Methods”. The solid circles determine wild type and rectangles represent
mutants.
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Extra Pulse of NBD-Cl
The inhibition with the extra pulse of NBD-Cl was very low. This experiment shows that
the NBD-Cl reacts particularly at βE catalytic sites and inhibits the reaction completely. Extra
Pulse of NBD-Cl is shown in Figure 5. An extra pulse retained the residual activity.

Figure 5: Results of Extra Pulse of NBD-Cl in Mutants: The membranes were incubated for
60min with 150µM NBD-Cl and an extra pulse of 200µM NBD-Cl was added and incubated for
another 60min. ATPase assay was performed as described in “Materials and Methods”. Each set
of bars from represent WT, wild type; 1, αD350R; 2, αD350Q; 3, αD350A; 4, αR376A; 5,
αG351R; 6, αR376D; 7, αD350R/αR376A; 8, αD350R/αR376D; 9, αG351R/αR376A;10,
αG351R/αR376A from left to right. The %Relative specific activities of the membranes are:
Wild type (100, 2.6, 2.1); αD350R (100, 22.6, 17.9); αD350Q ( 100,1.4,1.5); αD350A
(100,37,22); αR376A (100,38,30); αG351R (100,50,35); αR376D (100,19,10);
αD350R/αR376A (100,6,5); αD350R/αR376D (100,56,48); αG351R/αR376A (100,41,31);
αG351R/αR376A (100,39,35).

Reversal of ATPase Activity by DTT
DTT assay was performed to see whether the reaction can be completely reversed or not.
This assay is an indicative of specificity of reaction. NBD-adduct can be released from βTyr-297,
after incubating with DTT [30, 31]. The ATPase activity can be completely regained upon
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addition with DTT. The reversal of ATPase activity upon addition with DTT is shown in Figure
6.

Figure 6: Reversal of ATPase Activity by DTT: Membranes were incubated with NBD-Cl for 60
min, 4mM DTT was added and incubated again for another 60 min. ATPase assay was
performed as discussed in “Materials and Methods”. Each set of bars on the top figure represent
Wild type; psr1, αD350R; psr2, αD350Q; psr3, αD350A from left to right. Each set of bars in the
bottom figure represent Wild type; psr4,αR376A; psr5,αG351R; psr6,αR376D from left to
right.(Continued on the next page)
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Figure 6: Reversal of ATPase Activity by DTT: Membranes were incubated with NBD-Cl for 60
min, 4mM DTT was added and incubated again for another 60 min. ATPase assay was
performed as discussed in “Materials and Methods”. Each set of bars represent Wild type; psr7,
αD350R/αR376A; psr8, αD350R/αR376D; psr9, αG351R/αR376A; psr10,αG351R/αR376D;
from left to right in each group.

Protection Against NBD-Cl Reaction by MgADP
MgADP protected purified F1 and F1Fo in membrane from reaction with NBD-Cl, but
only at extremely high concentration that would effectively keep the third site (βE) occupied in
time average and thus impede access by NBD-Cl by closing the site [17]. MgADP protection
against NBD-Cl inhibition of wild type and mutants is shown in Figure 7.
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Figure 7: (Continued on the next page)
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Figure 7: Protection Against NBD-Cl Reaction by MgADP: Wild type and mutant membranes
were preincubated for 60 min at RT with varied concentrations of MgADP, then150µM of NBDCl was added, and incubation continued at RT in the dark for 60 min. The aliquots were then
assayed for ATPase Activity.

Protection by Pi Against NBD-Cl Inhibition
Pi protection against NBD-Cl inhibition of wild type and mutants is shown in Figure 8. Pi
protected well against NBD-Cl inhibition of ATPase activity in wild type as well as αD350Q,
αD350R, αD350A, αG351R, αR376D, αG351R/αR376A. αD350Q, αD350R, αD350A, αG351R,
αR376D, αG351R/αR376A regained Pi binding activity and the introduction of arginine at
αG351R compensated the loss of arginine at α376 position.
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Figure 8: Protection Against NBD-Cl by Pi: Membranes were preincubated with Pi at 0, 2.5, 5,
and 10mM concentration as shown, for 60 min at RT. Then NBD-Cl (150µM) was added and
aliquots were withdrawn for assay at time intervals. ATPase activity remaining is plotted against
time of incubation with NBD-Cl. (Continued on the next page)
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Figure 8: Protection Against NBD-Cl by Pi: Membranes were preincubated with Pi at 0, 2.5,5,
and 10mM concentration as shown, for 60 min at RT. Then NBD-Cl (150µM) was added and
aliquots were withdrawn for assay at time intervals. ATPase activity remaining is plotted against
time of incubation with NBD-Cl. (Continued on the next page)
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Figure 8: Protection Against NBD-Cl by Pi: Membranes were preincubated with Pi at 0, 2.5,
5and 10mM concentration as shown, for 60 min at RT. Then NBD-Cl (150µM) was added and
aliquots are withdrawn for assay at time intervals. ATPase activity remaining is plotted against
time of incubation with NBD-Cl.
Inhibition of ATPase Activity by Fluoroaluminate and Fluoroscandium
Inhibition of ATPase activity by transition state analogs is shown in Figure 9. Wild type
was strongly inhibited (~>95%) and αD350Q was also strongly inhibited. αR376A was inhibited
by 40%, αR376D by 80%, αD350R by 80%, αD350A by 60%, and αG351R by 60%. The
introduction of Arginine in αD350R/αR376A resulted in 80% inhibition and αG351R/αR376A
and αG351R/αR376D resulted in 40% inhibition. The inhibition of Wild type with
fluoroscandium is >98%, αD350Q, αD350R/αR376A by 80%, αG351R by 30%, αR376D by
60%, αD350A by 40%, αD350R/αR376D by 20%, αG351R/αR376D by 10%, and
αG351R/αR376A by 30%.
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Figure 9: Inhibition of ATPase Activity by Transition State Analogs: The membranes were
preincubated for 60 min at room temperature with 1mM MgADP, 10mM NaF, and the indicated
concentrations of AlCl3 or ScCl3.Then aliquots were added to 1 ml of assay buffer, and ATPase
activity was determined. (Continued on the next page)
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Figure 9: Inhibition of ATPase Activity by Transition State Analogs: The membranes were
preincubated for 60 min at room temperature with 1mM MgADP, 10mM NaF, and the indicated
concentrations of AlCl3 or ScCl3.Then aliquots were added to 1 ml of assay buffer, and ATPase
activity was determined.

41

CHAPTER 4

DISCUSSION

ATP synthase is one of the smallest known biological nanomotors. ATP synthase exists
in the body, interacting with any number of proteins and other molecules at any given time, so
why not use this enzyme as a base model to develop a tiny machine that can go inside our bodies
to perform various types of work?
Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical
interventions on the molecular scale for curing disease or repairing damaged tissues [40].
Unclogging arteries, fighting infections, or helping to monitor body systems are a few things
nanomachines might be capable of. But once a nanomachine is inside the body, how big can it
be? How fast can it work? Can we alter its speed? How many can we have to perform efficiently
without disrupting homeostasis? These questions must be addressed in order to build
nanomachines that are compatible with living tissues and can safely operate inside the body [41].
Currently, ATP synthase is the smallest known biological nanomotor. Therefore, understanding
the mechanisms of how this enzyme works and using ATP synthase as a base model may help to
develop nanomotors for nanomedicine usage.
ATP synthesis occurs by the phosphorylation of ADP. According to binding change
mechanism, ADP and phosphate enter the active site where the protein closes up around the
molecules and binds them tightly, thus releasing ATP molecule. This process involves several
residues and understanding the role of conserved residues in and around catalytic sites is the
primary goal of the project. Earlier it was found that positively charged residues are functionally
important for Pi binding in the βE catalytic site of E. coli ATP Synthase [20]. In certain other
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cases [32] introduction of negative charge in the Pi binding pocket close to βArg-246 prevented
Pi binding. This gave us an idea to modulate the sites that are very close to the phosphate binding
residues and understand the mechanism of phosphate binding. Previously, it was found that αSer347 of VISIT-DG sequence was involved in Pi binding. The residues αIle-346, αIle-348 and
αThr-349 were also modulated to see whether they play an important role in Pi binding or not.
The α-subunit VISIT-DG sequence residue aspartate (D) is ~2.8A0 from R376 of αsubunit [Fig 2]. The VISIT-DG sequence was chosen because of its conserved nature in many
organisms. Here we introduced the mutation αD350R (removal of negative charged side chain
and addition of positive charge), αD350Q (addition of bulky group), αD350A (removing charge
and size). Here, we mutated the known phosphate binding residue αArg-376 to alanine (A) and
tried to see its compensatory effect in αD350R background. We mutated αArg-376 to
aspartate(D) in which we removed positive charge side chain and added a negative charge and
tried to see the repulsive effect in normal background. The αGly-351 is mutated to arginine (R),
a positive charged side chain to see the effect on Pi binding in normal background.
The succinate and limiting glucose assays on the mutants showed partial loss of
oxidative phosphorylation and ATPase activities were very low when compared to the wild type
[Table 2].
NBD-Cl inhibition assay showed that αD350Q was just like wild type whereas αD350R,
αR376D, and αD350R/ αR376A are showing 80-90% inhibition with 10-20% residual activity
[Fig 4]. αD350A, αR376A, αG351R/αR376A, αG351R/αR376D showed 60% inhibition
compared to wild type [Fig 4].This indicates that NBD-Cl still reacted with βTyr-297 in the
mutants as in wild type and an extra pulse of NBD-Cl determined that it reacted particularly in
βE catalytic sites and inhibited the reaction completely [Fig 5]. DTT assay is an indicative of
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specificity of the reaction. NBD-Cl-adduct can be released from βTyr-297 after incubating with
DTT [30, 31]. The mutants regained the activity indicating the release of NBD-Cl adducts from
βTyr-297 [Fig 6]. The rate of inactivation was linearly dependant on NBD-Cl concentration and
protection occurs at high concentrations of MgADP. All the mutants regained their phosphate
binding activity when protected against NBD-Cl by MgADP [Fig 7].
Earlier studies established that mutagenesis combined with the use of the Pi protection
assay against NBD-Cl inhibition, as well as the use of inhibitory analogs, enabled
characterization of functional role(s) of residues suspected to be involved in Pi binding [36-38].
αD350R, αD350Q, αD350A mutants showed Pi binding where as αR376A mutant abrogated Pi
binding in presence of wild type because of the loss of positive side chain of arginine residue
[Fig 8]. Similarly, αG351R didn’t show any Pi binding in presence of αR376D. However the
introduction of arginine at α350 position compensated the loss of arginine at α376 position and
regained the Pi binding activity. However, αD350R/αR376D showed partial gain in Pi binding
[Fig 8]. The reasons for this might be the effect of charge and introduction of bulky groups. The
growth on succinate and ATPase activities also supported the Pi protection assays.
Fluoroaluminate and fluoroscandium in combination with MgADP potently inhibit wild
type E. coli ATP synthase [20-21, 36-37] and both are believed to mimic the chemical transition
state. Transition state-like structures involving bound MgADP-AlF4- complex have been seen in
catalytic sites in ATP synthase by x-ray crystallography [21]. It was observed from the
fluoroaluminate and fluoroscandium experiments that there is a de-stabilization in transition state
in αR376A, αG351R, αG351R/αR376D and αG351R/αR376A which was supported by Pi
binding experiments [Fig 9]. The partial transition state stabilization is seen in the rest of the
mutants, which is in agreement with Pi binding and oxidative phosphorylation. This shows that
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there is a functional impairment in all the mutants. There is no loss of transition state
stabilization in αD350Q that acts similar to wild type [Fig 9] .This may be due to the bulky
nature of the amino group and its role in catalysis might be indirect.
From the results, we can conclude that the introduction of positive charged residue
arginine (R) at αD350 position resulted in the catalysis of ATP synthase and thus played an
important role in Pi binding, whereas the introduction of alanine (A) in αD350 is involved in
partial transition state stabilization. The αD350Q mutant was inhibited completely by NBD-Cl
and regaining the Pi binding activity just like the wild type. It also showed loss of transition state
stabilization indicating that the introduction of a bulky group doesn’t have any effect in Pi
binding. The mutant αR376A abrogated the Pi binding and showed a destabilized transition state
in fluoroaluminate and fluoroscandium experiments. This shows that αR376 is an important Pi
binging residue that was already known [22]. The introduction of arginine in αD350
compensated the loss of arginine at α376 (αR376A) position. NBD-Cl showed 80-90%
inhibition, Pi binding was completely regained and transition state stabilization was seen. This
indicates that the introduction of positive charge in αD350 position compensated the loss of
arginine at α376 .Thus, we can say that αD350R/αR376A plays an important role in Pi binding.
The mutant αD350R/αR376D didn’t show much difference in Pi binding and also in
transition state stabilization. The mutant’s αG351R, αG351R/αR376A/D didn’t show any
significant difference. They showed partial inhibition with NBD-Cl and partial transition state
stabilization by fluoroaluminate and fluoroscandium experiments. This indicates that αG351 may
not be involved in Pi binding but may be involved in structural integrity of the ATP synthase.
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Thus, we can accept the hypotheses that αD350 may be involved in Pi binding directly
and is functionally important residue for maintaining structural integrity. This hypothesis was
even supported by the compensatory effect of αD350. However, αG351 may not be involved in
Pi binding directly but may be involved in structural integrity.
In the future, in order to confirm that αD350 plays an important role in Pi binding
directly, we need to perform X-Ray crystal studies and determine the role played by the residues.
The results shown were only from one set of membranes. So, in order to confirm the effect of
mutations, assays need to be performed with another set of membranes. The effect of mutations
on folding has to be determined through fluorescence studies.

46

REFERENCES

1. Slater EC. 1953. Mechanism of phosphorylation in the respiratory chain. Nature
172(4387):975-8.
2. Brodie AF, Gray CT. 1956. Activation of coupled oxidative phosphorylation in bacterial
particulates by a soluble factor (s). Biochim Biophys Acta 19(2):384-6.
3. Penefsky HS, Pullman ME, Datta A, Racker E. 1960. Partial resolution of the enzymes
catalyzing oxidative phosphorylation. II. Participation of a soluble adenosine
tolphosphatase in oxidative phosphorylation. J Biol Chem 235:3330-6.
4. Mitchell P. 1961. Coupling of phosphorylation to electron and hydrogen transfer by a
chemi-osmotic type of mechanism. Nature 191:144-8.
5. Weber J, Senior AE. 2003. ATP synthesis driven by proton transport in F1F0-ATP
synthase. FEBS Lett 545(1):61-70.
6. Senior AE, Nadanaciva S, Weber J. 2002. The molecular mechanism of ATP synthesis
by F1F0-ATP synthase. Biochim Biophys Acta 1553(3):188-211.
7. Noji H, Yoshida M. 2001. The rotary machine in the cell, ATP synthase. J Biol Chem
276(3):1665-8.
8. Leslie AG, Walker JE. 2000. Structural model of F1-ATPase and the implications for
rotary catalysis. Philos Trans R Soc Lond B Biol Sci 355(1396):465-71.
9. Rosing J, Kayalar C, Boyer PD. 1977. Evidence for energy-dependent change in
phosphate binding for mitochondrial oxidative phosphorylation based on measurements
of medium and intermediate phosphate-water exchanges. J Biol Chem 252(8):2478-85.
10. Boyer PD. 1989. A perspective of the binding change mechanism for ATP synthesis.
FASEB J 3(10):2164-78.
11. al-Shawi MK, Senior AE. 1992. Catalytic sites of Escherichia coli F1-ATPase.
Characterization of unisite catalysis at varied pH. Biochemistry 31(3):878-85.
12. Weber J, Lee RS, Wilke-Mounts S, Grell E, Senior AE. 1993. Combined application of
site-directed mutagenesis, 2-azido-ATP labeling, and lin-benzo-ATP binding to study the
noncatalytic sites of Escherichia coli F1-ATPase. J Biol Chem 268(9):6241-7.
13. Ahmad Z, Senior AE. 2005. Identification of phosphate binding residues of Escherichia
coli ATP synthase. J Bioenerg Biomembr 37(6):437-40.

47

14. Weber J, Bowman C, Wilke-Mounts S, Senior AE. 1995. alpha-Aspartate 261 is a key
residue in noncatalytic sites of Escherichia coli F1-ATPase. J Biol Chem 270(36):210459.
15. al-Shawi MK, Parsonage D, Senior AE. 1989. Kinetic characterization of the unisite
catalytic pathway of seven beta-subunit mutant F1-ATPases from Escherichia coli. J Biol
Chem 264(26):15376-83.
16. Wise JG, Senior AE. 1985. Catalytic properties of the Escherichia coli proton
adenosinetriphosphatase: evidence that nucleotide bound at noncatalytic sites is not
involved in regulation of oxidative phosphorylation. Biochemistry 24(24):6949-54.
17. Orriss GL, Leslie AG, Braig K, Walker JE. 1998. Bovine F1-ATPase covalently inhibited
with 4-chloro-7-nitrobenzofurazan: the structure provides further support for a rotary
catalytic mechanism. Structure 6(7):831-7.
18. Perez JA, Greenfield AJ, Sutton R, Ferguson SJ. 1986. Characterisation of phosphate
binding to mitochondrial and bacterial membrane-bound ATP synthase by studies of
inhibition with 4-chloro-7-nitrobenzofurazan. FEBS Lett 198(1):113-8.
19. Menz RI, Walker JE, Leslie AG. 2001. Structure of bovine mitochondrial F(1)-ATPase
with nucleotide bound to all three catalytic sites: implications for the mechanism of
rotary catalysis. Cell 106(3):331-41.
20. Ahmad Z, Senior AE. 2004. Mutagenesis of residue betaArg-246 in the phosphatebinding subdomain of catalytic sites of Escherichia coli F1-ATPase. J Biol Chem
279(30):31505-13.
21. Ahmad Z, Senior AE. 2004. Role of betaAsn-243 in the phosphate-binding subdomain of
catalytic sites of Escherichia coli F(1)-ATPase. J Biol Chem 279(44):46057-64.
22. Li W, Brudecki LE, Senior AE, Ahmad Z. 2009. Role of {alpha}-subunit VISIT-DG
sequence residues Ser-347 and Gly-351 in the catalytic sites of Escherichia coli ATP
synthase. J Biol Chem 284(16):10747-54.
23. Miller EM, Nickoloff JA. 1995. Escherichia coli electrotransformation. Methods Mol Biol
47:105-13.
24. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1987.
Current Protocols in Molecular Biology. John Wiley & Sons, NY.
25. Braman J, Papworth C, Greener A. 1996. Site-directed mutagenesis using doublestranded plasmid DNA templates. Methods Mol Biol 57:31-44.

48

26. Nelson M, McClelland M. 1992. Use of DNA methyltransferase/endonuclease enzyme
combinations for megabase mapping of chromosomes. Methods Enzymol 216:279-303.
27. Senior AE, Langman L, Cox GB, Gibson F. 1983. Oxidative phosphorylation in
Escherichia coli. Characterization of mutant strains in which F1-ATPase contains
abnormal beta-subunits. Biochem J 210(2):395-403.
28. Senior AE, Latchney LR, Ferguson AM, Wise JG. 1984. Purification of F1-ATPase with
impaired catalytic activity from partial revertants of Escherichia coli uncA mutant strains.
Arch Biochem Biophys 228(1):49-53.
29. Taussky HH, Shorr E. 1953. A microcolorimetric method for the determination of
inorganic phosphorus. J Biol Chem 202(2):675-85.
30. Ferguson SJ, Lloyd WJ, Lyons MH, Radda GK. 1975. The mitochondrial ATPase.
Evidence for a single essential tyrosine residue. Eur J Biochem 54(1):117-26.
31. Ferguson SJ, Lloyd WJ, Radda GK. 1975. The mitochondrial ATPase. Selective
modification of a nitrogen residue in the beta subunit. Eur J Biochem 54(1):127-33.
32. Ahmad Z, Senior AE. 2005. Involvement of ATP synthase residues alphaArg-376,
betaArg-182, and betaLys-155 in Pi binding. FEBS Lett 579(2):523-8.
33. Braig K, Menz RI, Montgomery MG, Leslie AG, Walker JE. 2000. Structure of bovine
mitochondrial F(1)-ATPase inhibited by Mg(2+) ADP and aluminium fluoride. Structure
8(6):567-73.
34. Penefsky HS. 2005. Pi binding by the F1-ATPase of beef heart mitochondria and of the
Escherichia coli plasma membrane. FEBS Lett 579(10):2250-2.
35. Copley RR, Barton GJ. 1994. A structural analysis of phosphate and sulphate binding
sites in proteins. Estimation of propensities for binding and conservation of phosphate
binding sites. J Mol Biol 242(4):321-9.
36. Ahmad Z, Senior AE. 2005. Modulation of charge in the phosphate binding site of
Escherichia coli ATP synthase. J Biol Chem 280(30):27981-9.
37. Ahmad Z, Senior AE. 2006. Inhibition of the ATPase activity of Escherichia coli ATP
synthase by magnesium fluoride. FEBS Lett 580(2):517-20.
38. Brudecki LE, Grindstaff JJ, Ahmad Z. 2008. Role of alphaPhe-291 residue in the
phosphate-binding subdomain of catalytic sites of Escherichia coli ATP synthase. Arch
Biochem Biophys 471(2):168-75.
39. Weber J, Senior AE. 2000. ATP synthase: what we know about ATP hydrolysis and what
we do not know about ATP synthesis. Biochim Biophys Acta 1458(2-3):300-9.
49

40. Nanomedicine Overview. 2010. National Institutes of Health. Division of Program
Coordination, Planning, and Strategic Initiatives. Bethesda, Maryland, USA. Accessed
Nov., 2010. http://nihroadmap.nih.gov/nanomedicine/
41. Whitesides, G. M. (2003) The 'Right' Size in Nanobiotechnology. Nat Biotechnol
21:1161-5.
42. Weber J. 2007. ATP synthase--the structure of the stator stalk. Trends Biochem Sci
32(2):53-6.

50

APPENDICES

APPENDIX A- Abbreviations
VISIT-DG- Valine-Isoleucine-Serine-Isoleucine-Threonine-Aspartate-Glutamate
ATP- Adenosine triphosphate
ADP- Adenosine diphosphate
Arg [R]- Arginine
Lys [L]- Lysine
Ser [S]- Serine
Gly [G]- Glycine
Asp [D]- Aspartate
Ala [A]- Alanine
Tyr- Tyrosine
AMP-PNP- Adenylyl imidodiphosphate
βTP- β triphosphate
βDP- β diphosphate
βE- β empty
NBD-Cl- 4-chloro-7-nitrobenzofurazan
MgADP- Magnesium adenosine diphosphate
AlF4-- Fluoroaluminate
TRIZMA- Tris [Hydroxyethyl] ethane
PAB- 4-aminobenzamidine
SDS- Sodium dodecyl sulphate
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IPTG- Isopropyl-β-D-1- thio-galactopyranoside
X-Gal- 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside
DTT-Dithiothreitol
NaF- Sodium fluoride
Alcl3- Aluminum Chloride
Sncl3- Scandium Chloride
T&S- Taussky and Shorr
O.D- Optical density
ATPcktl- ATP cocktail
Mbr- Membrane
Inc-Incubate
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APPENDIX B- Buffers and Reagents
50 mM Tris-SO4 buffer
To 90 ml H2O add
0.61 g Tris
Adjust pH to 8.0 with H2SO4
Bring to a final volume of 100 ml with H2O
ATPase cocktail
In 150 ml H2O add
10 ml 1 M Tris
0.8 ml 1M MgCl2
5 ml 0.4 Na ATP (Adenosine 5̍-triphosphate disodium salt)
Adjust pH to 8.5 with H2SO4
Bring to a final volume of 200 ml with H2O
Freeze in plastic bottles at -20°C
10 % SDS
100 gm Sodium dodecyl sulfate
Bring to a final volume of 1000 ml with H2O
T & S reagent / Taussky and Shorr reagent
Sol A: 1.2 g Ammonium molybdate ((NH4)6Mo7O24·4H2O in 9.8 ml 12 N H2SO4)
Sol B: 10 g Ferrous ammonium sulfate (Fe(NH4)2(SO4)2·6H2O in 70 ml H2O)
Add sol A to sol B while stirring
Bring to a final volume of 100 ml with H2O
Store at 4°C
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STEM
To 700 ml H2O add
100 ml 1 M TES
4.29 g Mg (CH3CO2)2·4H2O
85.5 g sucrose
0.0951 g EGTA (Ethylene glycol-bis(2-aminoethylether)-N,N,N,N-tetraacetic acid)
5 g EACA (6-Ainocaproic acid6-Ainocaproic acid)
Adjust pH to 6.5 with NaOH
Bring to a final volume of 1000 ml with H2O
Freeze in plastic bottles at -20°C
TES 50
To 700 ml H2O add
50 ml 1 M TES
150 ml glycerol
5 g EACA (6-Ainocaproic acid6-Ainocaproic acid)
1 g PAB (4-Aminobenzamidine dihydrochloride)
Adjust pH to6.5 with NaOH
Bring to a final volume of 1000 ml with H2O
Freeze in plastic bottles at -20°C
TES 5 + PAB
To 700 ml H2O add
5 ml 1 M TES
150 ml glycerol
1 ml 0.5 M DTT (Dithiothreitol)
5 g EACA (6-Ainocaproic acid6-Ainocaproic acid)
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1 g PAB (4-Aminobenzamidine dihydrochloride)
2.5 ml 0.2 M EDTA (Ethylenediaminetetraacetic acid disodium salt dihydrate)
Adjust pH to 6.5 with NaOH
Freeze in plastic bottles at -20°C
AET (Arginine Ent Thiamine)
To 60 ml H2O add
0.617 g 2, 3 dihydroxy benzoic acid
16.86 g L-Arginine HCl
1 ml 20 mM Thiamine
Add just enough amount of NaOH to dissolve everything
Make final volume to 100 ml with H2O
Filter sterile and store.
TE (Trace Elements)
To 80 ml H2O
0.251 g Zinc Sulfate (ZnSO4.7H2O)
0.017 g Manganese Sulfate (MnSO4.H2O)
0.029 g Boric acid (H3BO3)
0.012 g Calcium Sulfate (CaSO4.2H2O)
0.037 g Calcium Chloride (CaCl2.2H2O)
0.049 g Ferric Chloride (FeCl3.6H2O)
Make final volume to 100 ml with H2O.
Filter sterile and store.
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ILV (Isoleucin-Valine)
To 95 ml H2O add
0.394 g Isoleucine
0.352 g Valine
Make final volume to 100 ml with H2O
Filter sterile

10x Reaction buffer
100 mM KCl
100 mM (NH4)2SO4
200 mM Tris-HCl (pH 8.8)
20 mM MgSO4
1% Triton® X-100
1 mg/ml nuclease-free bovine serum albumin (BSA)
Cell lysis solution
0.2M NaOH
1% SDS
Cell resuspension solution
50mM Tris-HCl (pH 7.5)
10mM EDTA
100µg/ml RNase A
Column wash solution
162.8mM Potassium acetate
22.6mM Tris-HCl (pH 7.5)
0.109mM EDTA (pH 8.0)
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Neutralization solution
4.09M Guanidine hydrochloride
0.759M Potassium acetate
2.12M Glacial acetic acid
Adjust the final pH to approximately 4.2.

57

APPENDIX C- Culture Media and Plates
LB liquid medium:
12.5 g of LB broth powder
Add H2O to bring to 500 ml
Autoclave for 30 minutes
Cool the media to ~50°C
Add 500 µl of 100 mg/ml Ampicillin
Minimal Glucose:
To 400 ml H2O add
5.225 g Potassium Phosphate Dibasic Trihydrate (K2HPO4)
2.40 g Sodium Phosphate Monobasic (NaH2PO4)
0.99 g Ammonium Sulfate ((NH4)2SO4)
Autoclave for 30 min, cool it and add the following additions
10 ml Uracil
10 ml 27 % Glucose
5 ml ILV (isoleucin-valine)
0.5 ml TE (trace elements)
0.5 ml 1 M Magnesium Sulfate (MgSO4)
0.5 ml AET (Arginine Ent Thiamine)
0.5 ml 100 mg/ml Ampicillin
0.312 ml 4X LB
LB-Agar plate with Ampicillin:
12.5g of LB broth powder
7.5g of Agar
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Bring to a final volume of 500 ml
Autoclave for 30 minutes
Cool the media to ~50°C
Add 500 µl of 100 mg/ml Ampicillin
Pour into sterile plates
NZY+ broth:
To 900 ml of deionized water, add

10 g of NZ amine (casein hydrolysate)
5 g of Yeast extract
5 g of NaCl
Adjust to pH 7.5 using NaOH and make the final volume to 1 liter.
Autoclave and add the following filer-sterilized supplements prior to use:
12.5 ml of 1 M MgCl2
12.5 ml of 1 M MgSO4
and 10 ml of 2M glucose or 20 ml of 20% (w/v) glucose.
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